C. EFRATA, T. R&D INTENSITY AND IPO UNDERPRICING: CASE STUDY ON PHARMACEUTICAL AND BIOTECH INDUSTRIES IN THE US. Journal of Accounting and Investment, [S. l.], v. 9, n. 1, p. 1–21, 2016. Disponível em: https://journal.umy.ac.id/index.php/ai/article/view/1083. Acesso em: 1 oct. 2025.